Phase II Study on HIPEC's Impact on PD-L1 in Advanced Gastric Cancer
The study aims to evaluate the upregulation of PD-L1 expression in peritoneal metastases from gastric cancer following HIPEC treatment.
Indication
Clinical and regulatory intelligence for Gastric Cancer with 9 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.